News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,491 Results
Type
Article (8016)
Company Profile (139)
Press Release (475336)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166742)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238195)
Policy (17898)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (483)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33155)
ALS (103)
Alzheimer's disease (970)
Antibody-drug conjugate (ADC) (258)
Approvals (10353)
Artificial intelligence (313)
ASCO (159)
Autoimmune disease (202)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (106)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (135)
Brain cancer (28)
Breast cancer (503)
Cancer (3590)
Cardiovascular disease (214)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (473)
Cervical cancer (34)
Clinical research (47776)
Collaboration (1218)
Commercialization (2)
Compensation (1400)
Complete response letters (34)
COVID-19 (752)
CRISPR (63)
C-suite (721)
Cystic fibrosis (84)
Data (5548)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (337)
Diagnostics (4164)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (149)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (161)
Earnings (73173)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87507)
Executive appointments (685)
FDA (12325)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (899)
Gene editing (125)
Generative AI (9)
Gene therapy (310)
GLP-1 (286)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9308)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (61)
Immunology and inflammation (98)
Immuno-oncology (55)
Indications (153)
Infectious disease (938)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (41)
IPO (12380)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (2)
Liver cancer (44)
Longevity (15)
Lung cancer (496)
Lymphoma (245)
Machine learning (27)
Management (3)
Manufacturing (517)
Marketing (7)
MASH (116)
Medical device (8643)
Medtech (8772)
Mergers & acquisitions (14362)
Metabolic disorders (693)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (214)
Neuropsychiatric disorders (38)
Neuroscience (1799)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (219)
Opinion (10)
Ovarian cancer (157)
Pain (170)
Pancreatic cancer (191)
Parkinson's disease (197)
Partnered (11)
Patents (460)
Patient recruitment (488)
Peanut (31)
People (41155)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15441)
Phase 2 (21336)
Phase 3 (14366)
Pipeline (6759)
Policy (18)
Postmarket research (1570)
Preclinical (6527)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (188)
Rare diseases (558)
Real estate (3019)
Recruiting (6)
Regulatory (14731)
Reports (16)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (151)
Series B (119)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (313)
Venture capital (17)
Weight loss (72)
Women's health (76)
Date
Today (13)
Last 7 days (354)
Last 30 days (1136)
Last 365 days (19067)
2026 (11123)
2025 (19251)
2024 (22985)
2023 (26543)
2022 (34590)
2021 (37167)
2020 (33479)
2019 (23256)
2018 (17469)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18136)
2012 (20221)
2011 (20441)
2010 (20333)
Location
Africa (227)
Alabama (72)
Alaska (2)
Arizona (295)
Arkansas (11)
Asia (17856)
Australia (2092)
California (11611)
Canada (3066)
China (507)
Colorado (467)
Connecticut (397)
Delaware (205)
Europe (24585)
Florida (1738)
Georgia (366)
Hawaii (3)
Idaho (46)
Illinois (686)
India (45)
Indiana (310)
Iowa (13)
Japan (392)
Kansas (99)
Kentucky (30)
Louisiana (25)
Maine (25)
Maryland (1164)
Massachusetts (7646)
Michigan (300)
Minnesota (548)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2561)
New Mexico (12)
New York (2752)
North Carolina (1240)
North Dakota (4)
Northern California (5791)
Ohio (269)
Oklahoma (14)
Oregon (15)
Pennsylvania (2208)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4815)
Tennessee (114)
Texas (1875)
United States (37810)
Utah (351)
Vermont (1)
Virginia (147)
Washington D.C. (38)
Washington State (902)
West Virginia (1)
Wisconsin (73)
483,491 Results for "avitide inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Repligen Announces Agreement to Acquire Avitide Inc.
Repligen Corporation today announced that it has entered into a definitive agreement to acquire privately-held Avitide Inc.
September 16, 2021
·
5 min read
Avitide Finalizes Development of AVIPure®-COV2S, an Affinity Purification Resin for COVID-19 Vaccines
Avitide, Inc. the industry leader in the discovery and development of affinity purification chromatography resins, announced that it has finalized the development of an affinity bioprocess resin for the purification of recombinant COVID-19 vaccines
February 4, 2021
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Allergan and Avitide Expand Partnership to Develop Custom Affinity Chromatography Technologies
Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan.
January 13, 2020
·
2 min read
Business
Gemini Therapeutics and Avitide Enter Into Exclusive License Agreement
Avitide, Inc., the industry leader in the discovery and development of custom affinity purification resins, announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics’ therapeutic programs.
December 9, 2019
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Press Releases
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
July 30, 2026
·
6 min read
Press Releases
Axogen, Inc. Reports Second Quarter 2026 Financial Results
July 29, 2026
·
19 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
1 of 48,350
Next
